MX9305887A - Uso de acido hialuronico y formas para evitar restenosis arterial. - Google Patents
Uso de acido hialuronico y formas para evitar restenosis arterial.Info
- Publication number
- MX9305887A MX9305887A MX9305887A MX9305887A MX9305887A MX 9305887 A MX9305887 A MX 9305887A MX 9305887 A MX9305887 A MX 9305887A MX 9305887 A MX9305887 A MX 9305887A MX 9305887 A MX9305887 A MX 9305887A
- Authority
- MX
- Mexico
- Prior art keywords
- hyaluronic acid
- ways
- arterial restenosis
- avoid
- avoid arterial
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 3
- 229920002674 hyaluronan Polymers 0.000 title abstract 3
- 229960003160 hyaluronic acid Drugs 0.000 title abstract 3
- 206010051113 Arterial restenosis Diseases 0.000 title 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002079205A CA2079205C (en) | 1992-09-25 | 1992-09-25 | Use of hyaluronic acid and forms to prevent arterial restenosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9305887A true MX9305887A (es) | 1994-05-31 |
Family
ID=4150463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9305887A MX9305887A (es) | 1992-09-25 | 1993-09-24 | Uso de acido hialuronico y formas para evitar restenosis arterial. |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0661981B1 (forum.php) |
| JP (1) | JP3742955B2 (forum.php) |
| CN (1) | CN1057908C (forum.php) |
| AP (1) | AP448A (forum.php) |
| AT (1) | ATE141054T1 (forum.php) |
| AU (1) | AU670117B2 (forum.php) |
| BR (1) | BR9307221A (forum.php) |
| CA (1) | CA2079205C (forum.php) |
| CZ (1) | CZ288986B6 (forum.php) |
| DE (1) | DE69303931T2 (forum.php) |
| DK (1) | DK0661981T3 (forum.php) |
| ES (1) | ES2091031T3 (forum.php) |
| GR (1) | GR3021171T3 (forum.php) |
| HK (1) | HK35397A (forum.php) |
| HU (2) | HU227067B1 (forum.php) |
| IL (1) | IL107087A0 (forum.php) |
| IN (1) | IN181289B (forum.php) |
| MD (1) | MD960294A (forum.php) |
| MX (1) | MX9305887A (forum.php) |
| NO (1) | NO309457B1 (forum.php) |
| NZ (1) | NZ255978A (forum.php) |
| PL (1) | PL308201A1 (forum.php) |
| SG (1) | SG48845A1 (forum.php) |
| SK (1) | SK36895A3 (forum.php) |
| TW (1) | TW271401B (forum.php) |
| ZA (1) | ZA937068B (forum.php) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6663881B2 (en) | 1993-01-28 | 2003-12-16 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| ATE295745T1 (de) * | 1997-08-22 | 2005-06-15 | Denki Kagaku Kogyo Kk | Hyaluronsäure-gel, verfahren zur dessen herstellung und hyaluronsäure-gel enthaltendes medizinisches material |
| FR2813791B1 (fr) | 2000-09-14 | 2004-03-12 | Lafon Labor | Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale |
| US6613083B2 (en) | 2001-05-02 | 2003-09-02 | Eckhard Alt | Stent device and method |
| FR2994846B1 (fr) | 2012-08-29 | 2014-12-26 | Vivacy Lab | Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
-
1992
- 1992-09-25 CA CA002079205A patent/CA2079205C/en not_active Expired - Lifetime
-
1993
- 1993-09-22 JP JP50854394A patent/JP3742955B2/ja not_active Expired - Lifetime
- 1993-09-22 DE DE69303931T patent/DE69303931T2/de not_active Expired - Lifetime
- 1993-09-22 EP EP93920624A patent/EP0661981B1/en not_active Expired - Lifetime
- 1993-09-22 HU HU9500857A patent/HU227067B1/hu unknown
- 1993-09-22 ES ES93920624T patent/ES2091031T3/es not_active Expired - Lifetime
- 1993-09-22 BR BR9307221A patent/BR9307221A/pt not_active Application Discontinuation
- 1993-09-22 PL PL93308201A patent/PL308201A1/xx unknown
- 1993-09-22 SG SG1996002824A patent/SG48845A1/en unknown
- 1993-09-22 TW TW082107796A patent/TW271401B/zh active
- 1993-09-22 MD MD96-0294A patent/MD960294A/ro not_active Application Discontinuation
- 1993-09-22 SK SK368-95A patent/SK36895A3/sk unknown
- 1993-09-22 AP APAP/P/1993/000568A patent/AP448A/en active
- 1993-09-22 NZ NZ255978A patent/NZ255978A/en not_active IP Right Cessation
- 1993-09-22 CZ CZ1995662A patent/CZ288986B6/cs not_active IP Right Cessation
- 1993-09-22 DK DK93920624.9T patent/DK0661981T3/da active
- 1993-09-22 AT AT93920624T patent/ATE141054T1/de active
- 1993-09-22 AU AU48126/93A patent/AU670117B2/en not_active Expired
- 1993-09-23 IL IL107087A patent/IL107087A0/xx not_active IP Right Cessation
- 1993-09-24 MX MX9305887A patent/MX9305887A/es unknown
- 1993-09-24 ZA ZA937068A patent/ZA937068B/xx unknown
- 1993-09-24 CN CN93119844A patent/CN1057908C/zh not_active Expired - Fee Related
-
1995
- 1995-03-23 NO NO951122A patent/NO309457B1/no not_active IP Right Cessation
- 1995-06-13 IN IN670CA1995 patent/IN181289B/en unknown
- 1995-06-30 HU HU95P/P00651P patent/HU211698A9/hu unknown
-
1996
- 1996-09-26 GR GR960402522T patent/GR3021171T3/el unknown
-
1997
- 1997-03-20 HK HK35397A patent/HK35397A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9611015A (pt) | Composto, composição farmacêutica e processo para o tratamento de uma doença inflamatória suscetìvel ao tratamento com um agente não-tóxico anti-inflamatório não-esteróide, sal farmaceuticamente aceitável, utilização de um composto | |
| ES2082288T3 (es) | Composiciones terapeuticas para administracion intranasal de ketorolaco. | |
| ES2155473T3 (es) | Composicion veterinaria que contiene un inhibidor de las bombas de protones. | |
| BR9406979A (pt) | Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal | |
| ES467828A1 (es) | Un procedimiento para preparar nuevos compuestos de cefem y cefam | |
| MX9300904A (es) | Composiciones que contienen acido hialuronico | |
| ES2122076T3 (es) | Derivados de nor-acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos. | |
| ES2075011T3 (es) | Uso de sales del acido gamma-hidroxibutirico para preparar composiciones farmaceuticas para uso en el tratamiento del alcoholismo, y las composiciones obtenidas. | |
| MX9307779A (es) | Compuestos benzoicos fundidos. | |
| ES2139132T3 (es) | Composiciones farmaceuticas activas en la terapia de desordenes del sueño. | |
| ES2164920T3 (es) | Nuevos derivados heterociclicos y uso medicinal de los mismos. | |
| ECSP941104A (es) | Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| ES2158859T3 (es) | Estereoisomeros itraconazol y saperconazol. | |
| ES2176468T3 (es) | Uso de acido hialuronico y un nsaid para la fabricacion de un medicamento para el tratamiento de enfermedades de las mucosas. | |
| MX9300905A (es) | Tratamiento de enfermedad que emplea acido hialuronico y agentes anti-inflamatorios no esteroidales | |
| ES2093440T3 (es) | Derivados en la serie de la vitamina d con modificaciones en la posicion 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la preparacion de medicamentos. | |
| ES2143132T3 (es) | Monohidratos de derivado de acido aminobenceno-sulfonico y su metodo de preparacion. | |
| ES2157422T3 (es) | Trigliceridos y esteres etilicos de acido fenilalcanoico y acido fenilalquenoico utiles en el tratamiento de diversos trastornos. | |
| ES2145360T3 (es) | Sales cristalinas y estables de acido tetrahidrofolico. | |
| MX9305887A (es) | Uso de acido hialuronico y formas para evitar restenosis arterial. | |
| AR012504A1 (es) | Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion. | |
| MX171542B (es) | Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas | |
| ES479423A1 (es) | Procedimiento para la preparacion de 2-2-tenoiltio-propio- nil-glicina. | |
| ES8201167A1 (es) | Procedimiento para la obtencion de derivados de cefalospori-nas | |
| ES2087623T3 (es) | Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon. |